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Methemoglobinemia is an uncommon but potentially fatal disorder. Most cases have no adverse clinical 
consequence and require no treatment, but methemoglobinemia is often overlooked as a cause of low oxygen 
saturation, and often mistaken for the more common causes of hypoxia by anesthesiologists despite simple bedside 
tests that indicate the presence of this treatable abnormality. We present a 68-year-old female patient who underwent 
gastrectomy for advanced gastric cancer with bleeding. In the preoperative period, the patient showed cyanosis and 
oxygen saturation was 85% by pulse oximeter, but oxygen saturation by arterial blood gas analysis was 100%. After 
tracheal intubation, the methemoglobin level was 18.3%. Ascorbic acid and methylene blue were administered. 
During preanesthetic evaluation, the patient had not informed the anesthesiologist that she had been taking 
dapsone. (Korean J Anesthesiol 2010; 59: 340-343)
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    Methemoglobinemia is a hemoglobinopathy caused by high 
levels of methemoglobin that result from oxidation of ferrrous 
(Fe
2+) to the ferric state (Fe
3+) in hemoglogin. Methemoglobin 
cannot carry oxygen, leading to tissue hypoxia. Surgical 
patients rarely have methemoglobinemia, and most cases 
are mild and require no treatment. However, perioperative 
methemoglobinemia is often overlooked as a cause of low 
oxygen saturation, and is often mistaken for other pulmonary 
disorders such as atelectasis, pulmonary edema, pulmonary 
thromboembolism, or inadequate anesthetic care such as 
esophageal intubation. We report our experience of a dapsone-
induced methemoglobinemia detected during general 
anesthesia of a 68-year-old female patient who underwent 
gastrectomy for advanced gastric cancer with hemorrhage and 
perforation. 
Case Report
    A 68-year-old female patient with advanced gastric cancer 
presented for a gastrectomy. She was under drug treatment for 341 www.ekja.org
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diabetes and hypertension. Preoperative complete blood count 
showed hemoglobin at 8.9 g/dl and hematocrit at 26.5%. Arterial 
blood gas analysis was not performed. The electrocardiography, 
chest x-ray, and pulmonary function test showed no abnormal 
findings. 
    After arriving at the OR, the patient monitoring system 
(Poly  mount Philips, USA) was used to monitor the blood 
pressure, heart rate, pulse rate, and oxygen saturation by pulse 
oximeter. She appeared stable, with a heart rate of 85 bpm, 
blood pressure 134/80 mmHg, and respiratory rate 14 bpm, but 
oxygen saturation by pulse oximeter was 85% on both fingers 
but normal on the anesthesiologist’s finger. Oxygen 6 L/min 
was administered by mask, and no abnormal breathing sounds 
were detected. In arterial blood gas analysis, oxygen partial 
pre  ssure was 307 mmHg and oxygen saturation 100% (Table 1). 
However, the conjunctiva were pale; her lips and fingernails 
were cyanosed; and the oxygen saturation by pulse oximeter did 
not rise above 90%. The patient’s guardian indicated that she 
had a 10-year history of grayish lips and fingernails. Although 
we considered delaying the surgery, the guardian wanted the 
surgery to proceed and the patient had the advanced gastric 
cancer accompanied by hemorrhage and perforation. 
    Before the anesthesia, a 20 G catheter was placed in the radial 
artery for continuous hemodynamic monitoring and arterial 
blood gas analysis. After preoxygenation with oxygen at 6 L/
min, lidocaine 20 mg, propofol 120 mg, and vecuronium 10 
mg were administered, and manual ventilation was performed 
with oxygen at 6 L/min. However, the patient experienced 
severe cyanosis, and the oxygen saturation by pulse oximeter 
decreased to 79%. After the tracheal intubation and controlled 
ventilation with oxygen at 3 L/min, the pulse oximeter increased 
to 83-85%. In arterial blood gas analysis after induction, 
the sampled blood was dark blackish brown, oxygen partial 
pressure was 224.7 mmHg, and oxygen saturation was 96.6% 
(Table 1). The difference between oxygen saturation by arterial 
blood gas analysis and oxygen saturation by pulse oximeter 
was presumably due to dyshemoglobin. For confirmation, 
arterial blood gas analysis and hemoglobin analysis using a CO-
oximeter (ABL520, Radiometer, Cofenhagen, Denmark) was 
ordered for the department of laboratory medicine. Arterial 
blood gas analysis showed normal findings and hemoglobin 
analysis showed methemoglobin at 18.3% and oxyhemoglobin 
at 81.5%. Methemoglobinemia had caused cyanosis and low 
oxygen saturation by pulse oximeter. Ascorbic acid 600 mg 
mixed in fluid was administered, and methylene blue 1 mg/
kg was intravenously injected slowly over 3 minutes. The 
methemoglobin level reduced to 11.2% after the administration 
of ascorbic acid and reduced to 4.3% and then 2.3% after 
methylene administration. Anesthesia was sustained with 
oxygen at 3 L/min and enflurane 1.5-2.0 vol%. The surgery 
lasted 5 hours. The intraoperative oxygen saturation by pulse 
oximeter was 86-93%. Blood pressure and pulse rate were 
stable. Two U of packed red blood cells were transfused. After 
the surgery, the patient had a normal recovery of consciousness 
and spontaneous respiration, but was transferred to the 
intensive care unit (ICU). In the ICU, oxygen 6 L/min was 
administered by a Venturi mask. The oxygen saturation by pulse 
oximeter was 94%. One day after the surgery, we found that the 
patient had taken daspone 100 mg/day for 30 years for Hansen’s 
disease without her family ever knowing. After the surgery, 
methemoglobin in the blood went from 8.5% to 11.0%, but was 
untreated. From postoperative day 3, it was treated under the 
diagnosis of adrenal apoplexy due to hypotension. She was 
discharged without complications on postoperative day 30.
Discussion
    Methemoglobin forms when hemoglobin’s Fe ion oxides from 
ferrous (Fe
2+) to ferric (Fe
3+). In healthy adults, a small amount 
of hemoglobin oxides to methemoglobin and then it is rapidly 
Table 1. Serial Arterial Blood Gas Analysis
pH
PaCO2
(mmHg)
PaO2
(mmHg)
SaO2
(%)
SpO2
(%)
metHb
(%)
O2Hb
(%)
Before induction
  (mask 6 L/min)
After intubation
  (FiO2 1.0)
After AA administration
  (FiO2 1.0)
After MB administration
  (FiO2 0.5)
After extubation
  (mask 6 L/min)
POD 1 day
7.547
7.503
7.357
7.349
7.375
7.388
33.2
31.7
33.3
33.6
38.1
35.3
307
224.7
387.1
108.4
136.1
116.2
100
96.6
98.6
97.8
96.4
100.0
85
83-85
85-86
92-93
94
90-92
18.3
11.2
4.3
2.3
8.6
81.5
86.5
92.8
93.8
89.1
AA: ascorbic acid, MB: methylene blue, SaO2: oxygen saturation by ABGA, SpO2: oxygen saturation by pulse oximeter, metHb: methemoglobin, 
O2Hb: oxyhemoglobin,  FiO2: inspired oxygen fraction. 342 www.ekja.org
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converted back to hemoglobin such that methemoglobin 
levels remain below 1%. This balance is maintained by 
the intracellular enzyme systems, NADH cytochrome-b5 
methemoglobin reductase and NADPH methemoglobin 
reductase [1]. Methemoglobin cannot reversibly bind with 
oxygen or carbon monoxide because of its additional cation, 
so it reduces the oxygen-carrying capacity in arterial blood. It 
also causes a leftward shift of the oxygen dissociation curve, 
increasing the affinity of the hemoglobin for oxygen and 
reducing tissue oxygen supply. 
    Symptoms of methemoglobinemia are primarily related to the 
level of methemoglobin but are also influenced by other factors, 
such as the total hemoglobin level and the cardiovascular status 
and the respiratory function. Usually, at methemoglobin levels 
below 15%, patients have no clinical symptoms if adequate 
hemoglobin levels and preserved cardiac output is sufficient. 
However, when methemoglobin levels are 15-20%, black-
brown blood and cyanosis occur. Higher levels (20-45%) cause 
headaches, somnolence, tachycardia, lethargy, and dizziness. 
When it is 45% or above, respiratory difficulty, acidemia, 
arrhythmia, heart failure, and seizures occur. When above 70%, 
there is a high risk of death [2].
    Methemoglobinemia can be caused congenitally, by certain 
foods, or by other unknown causes, but usually occurs when 
the patient is exposed to drugs or chemical substances that 
disturb the conversion of methemoglobin to hemoglobin and 
quicken the development of methemoglobin. When discovered 
in the perioperative period, it is usually due to the exposure of 
drugs or chemical substances such as: amyl nitrite, ethyl nitrite, 
sodium nitrite, silver nitrate, bismuth subnitrate, nitroglycerin, 
quinones, sulfonamide, sulfapyridine, sulfathiazole, aniline 
dye, acetanilid, aminobenzenes, aminophenol, benzocaine, 
prilocaine, and phenacetin [3]. The drugs used in anesthetic 
practice that cause methemoglobinemia are prilocaine, 
benzocaine, amyl nitrite, nitroglycerine, phenacetin, and 
sulfonamide. Drug exposure and subsequent perioperative 
hypoxia may therefore indicate methemoglobinemia.
    Dapsone is a sulfone antibiotic used for the treatment of 
Hansen’s disease and other dermatologic diseases, as well as in 
immunosuppressed patients to prevent pneumocystitis carinii 
pneumonia or organ transplant patients, especially those 
intolerant to sulfonamide. Methemoglobinemia is a known 
side-effect of dapsone [4-6] and the patients of most cases had 
a history of dapsone-intake. The patient here had a 30-year 
history of dapsone-intake, although this information was not 
obtained initially. Dapsone is almost completely absorbed 
in the gastrointestinal track and passes the enterohepatic 
circulation. Only 20% of the dosage-intake is excreted into the 
urine. The plasma half-life varies from 10 to 80 hours and is 
dose-dependent. 
    The pulse oximeter uses 2 wavelengths, 660 nm and 990 nm, to 
calculate oxygen saturation because the absorbance difference 
between oxyhemoglobin and deoxyhemoglobin is maximized. 
Methemoglobin has the same absorbability as oxyhemoglobin 
and deoxygemoglobin so can affect oxygen saturation 
measurements by pulse oximeter [7]. Low methemoglobin 
levels slight decrease oxygen saturation measurements to a 
limit of 85%, even with fatal methemoglobin levels. Therefore, 
the pulse oximeter cannot monitor methemoglobin levels. 
Arterial blood gas analysis calculates oxygen saturation based 
on arterial oxygen tension and the temperature and may 
not reflect actual oxygen saturation. Methemoglobinemia 
diagnosis includes cyanosis; low arterial oxygen saturation 
that cannot be explained by a problem in the respiratory 
system or cardiovascular system; and when the normal oxygen 
partial pressure in the arterial blood gas analysis does not 
align with the oxygen saturation by the pulse oximeter. Oxygen 
carrying status is most accurately measured by analysis of all 
hemoglobin types with a CO-oximeter [7]. Methemoglobinemia 
may cause blackish brown blood to remain so after exposure 
to air. Congenital, chronic methemoglobinemia involves a 
family history or exposure to drugs and toxins, which could 
be captured in an accurate history. Here, before anesthesia 
the patient showed cyanosis and low oxygen saturation on 
the pulse oximeter, which did not align with the arterial blood 
gas analysis. However, the diagnosis of dyshemoglobins was 
delayed because of the patient refusal to share her medical 
history. 
    Methemoglobin levels were 18.3% initially, and the patient 
had asymptomatic cyanosis and was hemodynamically stable, 
but she was given immediate treatment. Despite adequate 
manual ventilation with oxygen at 6 L/min during anesthetic 
induction, the patient developed worsened cyanosis and 
showed decreased oxygen saturation by pulse oximeter to 79%. 
The eldely patient had diabetes, hypertension, and anemia, 
potentially indicating ischemic heart disease or impairment 
in the oxygen-carrying capacity. Ascorbic acid and methylene 
blue treatment reduced methemoglobin levels to 11.2%, 4.3%, 
followed by maintenance of hemoglobin level with 2 U of 
packed red cells.
    Cyanosis and 85% oxygen saturation on pulse oximeter before 
anesthesia could indicate high methemoglobin levels. Despite 
adequate preoxygenation and manual ventilation with oxygen 
at 6 L/min anesthesia reduced oxygen saturation by pulse 
oximeter to 79% and the cyanosis worsened. The anesthetics 
propofol, vecuronium, and enflurane are not oxidants that 
develop methemoglobin, although local anesthetics like 
prilocaine and benzocaine do, and it is uncertain that lidocaine 
is a oxidant [8]. After tracheal intubation and manual ventilation 
with oxygen at 6 L/min, the pulse oximeter went up to 84-85% 343 www.ekja.org
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and cyanosis decreased. Therefore, reduced oxygen saturation 
during anesthetic induction resulted from normal respiratory 
depression and not anesthetic drugs [8]. In healthy patients, the 
slight respiratory depression and reduced arterial oxygen partial 
pressure caused respiratory depressants may be ignored, but 
in methemoglobinemia, they may cause seriously low oxygen 
saturation. 
    Methemoglobinemia treatment is immediate intravenous 
administration of methylene blue (1-2 mg/kg) and the removal 
of toxins or drugs that could cause it. Methylene blue acts as 
a cofactor of methemoglobin reductase and accelerates the 
enzymatic breakdown of methemoglobin. Methylene blue may 
be readministered every 30-60 minutes [9]. Higher levels (4-15 
mg/kg/day) can directly oxidize hemoglobin to methemoglobin 
and cause hemolytic anemia in glucose-6-phosphate dehydro-
genase deficient patients. Methemoglobin levels above 30% 
should be treated, but methemoglobin levels below 15% may 
seem clinically insignificant. However even when the methemo-
globin level is low, treatment is recommended for patients 
with symptoms or underlying diseases with decreased oxygen-
carrying capacity such cardiac disease, pulmonary disease, 
carbon monoxide intoxication, anemia, or acidosis [10]. Life-
threatening methemoglobinemia unresponsive to methylene 
blue may occasionally respond to ascorbic acid as well, although 
ascorbic acid works slowly. Other reported treatments are homo  -
geneous transfusion, exchange transfusion, and hyper  baric 
oxygen treatment.
    In conclusion, methemoglobinemia is rare, but can be caused 
by drugs or chemical substances. The anesthesiologist should 
perform pulse oximeter and arterial blood gas analysis on 
patients with cyanosis. When the two results do not align, 
or when the oxygen saturation by pulse oximeter does not 
align with the clinical manifestations, methemoglobinemia 
should be suspected. The presence of dyshemoglobin should 
be confirmed by performing a hemoglobin analysis with a 
CO-oximeter. Methemoglobinemia should be treated with 
methylene blue when necessary according to methemoglobin 
level, symptom, and underlying diseases.
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